Blackthorn Therapeutics Stock

blackthornrx.comBioTechFounded: 2015Funding to Date: $130.3MM

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders.

Register for Details

For more details on financing and valuation for Blackthorn Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Blackthorn Therapeutics.

Register Today

Team

Management Team

William Martin Ph.D
Co-Founder, President, Chief Executive Officer & Board Member
Monique Levy
Chief Strategy Officer
Edward Roberts Ph.D
Scientific Co-Founder
Jane Tiller MD
Chief Medical Officer
Hugh Rosen Ph.D
Scientific Co-Founder
Paul Berns
Executive Chairman

Board Members

Asish Xavier Ph.D
Johnson & Johnson Innovation - JJDC
Brian Chee
Polaris Partners
John MacPhee
Julie Sunderland
Biomatics Capital
Kristina Burow
ARCH Venture Partners
Lori Hu
Vertex Ventures HC
Matthew Fust
Paul Berns
William Martin Ph.D

Other companies like Blackthorn Therapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$3.1B
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.2B
Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$1.61B

News

BlackThorn Therapeutics, Inc., today announced the promotion of company co-founder and seasoned CNS drug discovery and development expert, William J.
There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting its technological approach to finding drugs that work will put …